Eli Lilly

Forecast & Rating32 analysts currently cover Eli Lilly, with about 78.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $1324.87, about 16.6% upside from the current price of $1136.11. Price targets range from $930.00 to $1600.00 — a wide spread, showing clear disagreement over just how much Eli Lilly can rise. Historically, about 99.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Eli Lilly closely still see room for the stock to rise. Data as of Sep 15, 2026; for reference only and not investment advice.